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  ABSTRACT 
Now days, life is becoming very stressful and fast. As many diseases originate due to this 
hectic lifestyle. One of the important disease is Hridaroga (Ischemic heart disease), which 
is responsible for many deaths in early age. In Ayurveda, Hridaroga & their symptoms are 
described in many textbooks. Management of Hridaroga is also very critical and 
important. In modern medicine, only expensive interventional procedures are described 
but on the other hand, Ayurvedic herbs are better, cost effective & good therapeutic 
option for IHD (Hridaroga). 
 The review emphasizes on various properties of Terminalia arjuna. Many clinical 
& animal studies on T.arjuna show its effect on ECG changes, LV functions & myocardial 
ischaemic reperfusion injury-etc. Besides this it also has antiatherosclerotic, 
anticoagulant, anti-infarction, hypolipidemic & hypotensive properties. So, Ayurvedic 
drug (T. arjuna) is a better option for the treatment of IHD (Hridaroga) because it can 
improve the quality of life in individuals & potentially save millions of lives. 
KEYWORDS: Terminalia arjuna, Hridaroga, Ischemic heart disease. 
INTRODUCTION
Today, in this modern era, Ischemic heart 
disease (IHD) is a leading cause of morbidity and 
mortality. This problem is affecting all economic 
groups of society and also responsible for large 
number of deaths all over the world. So, IHD is 
now considered a modern epidemic.1 
 The main aim of this review article is to 
explore the scientific basis for the Ayurvedic 
treatment of IHD with T. arjuna because Ayurvedic 
substances may provide maximum benefit with 
cost effectiveness, minimum side effect & increase 
patient’s compliance. 
Definition 
 In Ayurveda, IHD or Hridaroga, is clinically 
characterized by chest pain produced by 
increased work load on the heart. The pain starts 
from sternum and radiates to the left arm, neck 
and upper part of the abd.2 
Nidana (Etiopathogenesis) 
In Ayurveda, Kapha (atherosclerosis), 
unhealthy lifestyle, excessive indulgences in sleep, 
lack of exercise, sedentary habits, eating Kashaya 
(astringent) & Katu (bitter) food and stress are 
major causes.3, 4 
 According to modern, heart suffers from 
ischemia either due to increased demand or 
decreased supply. Basically, ischemia is caused by 
the insufficiency of oxygen and reduced 
availability of nutrient substrates and inadequate 
removal of metabolites.5 
Bheda (Types) 
 According to Ayurveda, there are 5 clinical 
descriptions of Ischemic heart disease 
(Hridaroga). 1) Vataja, 2) Pittaja, 3) Kaphaja, 4) 
Tridoshaja, 5) Krimija.6 
Complications 
 According the clinical descriptions of IHD 
the main complications are angina, myocardial 
infarction, pulmonary embolism, arrhythmia, 
fibrillations, pericarditis, cardiogenic shock and 
sudden ischemic death.7 
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Management 
The main aim of the treatment for all heart 
diseases is to promote Agni (bio-fire) and to purify 
the Srotas (channels) by Panchakarma (Mridu 
sweda, Vamana & Langhana) and use natural 
herbs that have hypolipedemic & antistress 
activity. There are many decoctions, medicated 
ghee, paste & powders for each type of diseases 
described in Ashtanga Hridaya & other Ayurvedic 
texts.3,6 
The main formulations of T. Arjuna are 
Kakubhadi choorna, Parthadyarista, Pushayanug 
choorna, Arjuna ghrit, Arvindasav, 
Ashwagandharisht, Devdarvyarishta etc.8 
Terminalia arjuna 
All the names of Arjun is mentioned in 
Bhagavatgita’8.Its bark contains B-citosterol, 
arjunic acid, arjunetin & fridelin. It also contains 
cal. Carbonate 34%, salts 9% & tannin 16%. It has 
Kashaya (astringent) rasa, Laghu & Ruksha guna, 
Katu vipaka (bitter) sheet (cold) Veerya with 
Hridya prabhav (cardiac effect).9,1O 
 Most of the Ayurvedic formulations contain 
the bark of T. arjuna, one of the most popular herb 
for the precaution and management of various 
cardiovascular diseases. The stem bark of this 
plant is used for medicinal purposes. 
Properties according to different Samhitas 
T.arjuna is used in Kaphapittajanya rogas, 
helps in wound healing, join the bones & 
heamostatic due to Kashaya (astringent) property. 
It is cardiotonic, gives strength to cardiac muscles 
& improves cardiac function & rhythm. It 
increases peripheral resistance by constricting 
capillaries which leads to rise in blood pressure. It 
prevents accumulation of fluid & thereby reduces 
oedema. It reduces urinary discharges & relieving 
burning & pain during micturition. It is also 
effective in diabetes & gonorrhoea. Its bark is used 
in heart diseases with milk (by Ksheerpaka 
method).11,12  
Scientific basis of T. arjuna 
 To explore the scientific basis for the use 
of T. arjuna, many pharmacological and clinical 
investigations are reviewed. It have been found 
that these studies include antiatherosclerotic, 
anti-infarction, anticoagulant & anticholesterol 
effects of T. arjuna. These all effects are 
cardioprotective and useful in management of 
IHD. 
 
 
Clinical studies 
 The usefulness of T. arjuna in IHD 
(Hridaroga) has been confirmed in many clinical 
studies. It has found to be a mild diuretic without 
any cardiotonic action, but beneficial. Decoction 
prepared by its bark showed clinical improvement 
in patients of CHF (42%), essential hypertension 
(62%) & cirrhosis of liver (40%), respectively.13 
 It was further tested in 30 patients of 
stable angina pectoris. After 1 month, 10% 
patients did not require sublingual nitrate. ECG 
improvement was found in terms of reduction in 
depth of Q-waves & T-waves and changes in ST 
segment configuration, decrease in heart rate, 
correction of rhythm disturbance was also noted. 
A significant reduction in weight was also 
evident.14 
 In a study, 500mg of T. arjuna extract was 
administered twice daily in 25 patients with CAD. 
After 3 months, reduction in treadmill test 
response was observed in 6 patients with 
decrease in frequency of angina attacks and use of 
sublingual nitrates15. 
In another study, 500mg T. arjuna was 
administered twice daily to 20 patients, 15 had 
stable angina (gr. A) & 5 had unstable angina (gr. 
B). In both groups, patients experienced increase 
in LV ejection fraction and reduction in frequency 
of angina. Treadmill testing on 10 patients of 
stable angina showed moderate to mild changes 
after 3 months of therapy.16 
In a double blind, crossover design, 
placebo controlled study, 500 mg of aqueous and 
alcoholic extract of the bark of T.arjuna was 
administered for every 8 hr to 12 patients of 
refractory chronic CHF (NYHA- classic). It was 
given in addition to maximal tolerable doses of 
conventional therapy. In this study, T.arjuna as 
compared with placebo was associated with 
following improvements- Symptoms and signs of 
heart failure, Improvement in NYHA classes (class 
iii), decrease in echo LV end systolic and end 
diastolic volume-etc. During second phase of 
study, (means 24 months) further improvement 
was found in all symptoms.17 
In an other double blind placebo 
controlled study, T.arjuna is compared with ISMN 
in chronic stable angina patients. 58 patients with 
evidence of provokable ischaemia on the tread 
mill exercise test received T. Arjuna 500mg, 
isosorbide mononitrate 40mg/day or a matching 
placebo for 1 week. The treatment led to 
improvement in clinical & treadmill exercise 
parameters as compared with placebo. These 
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were similar to those observed with ISMN therapy 
and the extract was well tolerated.18 
The antioxidant and hypocholesterolaemic 
effects of T.arjuna bark powder was compared 
with vitamin E, an known antioxidant, in a 
randomized control trial.105 patients were 
recruited and separated into three groups using 
lattin square design. Group 1 received placebo 
capsules, group 2 received vitamin E cap. (400 
units/day) and group 3 received bark of T.arjuna 
(500 mg/day) in cap. In this study, T.arjuna 
exhibited a significant antioxidant effect in 
comparison with vitamin E.19 
Animal studies 
T.arjuna has also been reported to posses 
hypolipedemic effect in rabbits fed T. arjuna bark 
for 3 months.20 In another study, rabbits fed bark 
of T. arjuna with a high cholesterol diet showed 
lesser increase in total cholesterol and 
triglycerides.21 The chronic oral administration of 
T.arjuna also prevented oxidative stress 
associated with myocardial ischemic reperfusion 
injury.22 An emulsion of T. Arjuna bark powder 
(10g/Kg) was given to rabbits orally for seven 
days. The treatment caused a significant increase 
in prothrombin time and decrease in platelet 
count. In a similar study with the alcoholic 
extract23,24, there was no change in prothrombin 
time. A water soluble portion of the total alcoholic 
extract of T.arjuna was found to cause an increase 
in the force of contraction of a frog heart25. In later 
studies, both negative and positive ionotropic 
effects were observed in isolated perfused frog 
and rabbit hearts and isolated frog and rat Atria26. 
The extract consists of a mixture of substances 
capable of exerting both positive and negative 
ionotropic effects27. The aqueous extract of 
T.arjuna was also found to produce dose 
dependent sustained hypotension and 
bradycardia in dogs28. These observations led the 
authors to propose that the active constituent in 
the extract acts centrally.  
In another study, it was observed that 
aortic prostaglandin E2 like activity was enhanced 
in ischemic rabbit aorta. Pre treated with T.arjuna 
because PGE2 causes coronary vasodilatation. This 
may explain the beneficial effect of T.arjuna in 
patients with coronary artery disease (CAD).29 In a 
subsequent study, Abana a herbal formula 
containing T.arjuna significantly increased 
Creatinine Phophokinase (CPK), Glutamate 
Oxaloacetate, Transaminase (GOT), Glutamate, 
Pyruvate, Transaminase (GPT) and Gamma 
Glutamyl Transpeptidase in serum following 
myocardial necrosis. The beneficial effect of Abana 
was further evident form the reduction in 
mitochondrial enzymes .30 
DISCUSSION 
 In recent years, traditional system of 
medicine including Ayurveda has been used in the 
management of IHD. T. arjuna is one of the 
popular Ayurvedic herb used by many 
practitioners for the prevention and management 
of IHD. According to Ayurveda, IHD is the outcome 
of stressful and sedentary lifestyle with wrong 
food pattern which leads to ama (i.e. 
hyperlipedemia) leading to Dhamni pratichaya 
(thickening of arteries) & Dhamani kathinya 
(hardening of arteries). The principal treatment is 
to promote Agni (bio-fire) and to purify all the 
channels by Panchakarma and to use natural 
drugs that have cardiotonic, hypolipedemic, 
anticoagulant and hypotensive properties. In all 
these studies, T. arjuna showed all these features. 
 In modern medicine, the treatment of IHD 
contains expensive interventional procedures, 
such as thrombolytic therapy and surgical 
recanalization. So, T. arjuna and other Ayurvedic 
herbs and drugs are best cost effective and 
acceptable therapeutic option for IHD. 
 The current review showed that T. arjuna 
provided relief in angina and its effect on ST 
segment changes & T-wave depression in IHD. 
There is no known side effect of this conventional 
therapy. 
CONCLUSION 
1. IHD is the outcome of sedentary lifestyle & 
faulty diet. 
2. The principle treatment is to promote Agni 
(biofire) & to purify the channels (Srotas). 
3. In the treatment of Hridroga, natural drugs 
should have cardiotonic, hypotensive, 
hypolipidaemic and haemostatic 
properties. 
4. In modern, the treatment involves 
expensive interventional procedures but 
T.arjuna shows better & cost effective 
treatment. 
5. The studies on T.arjuna shown 
improvement in LV function, ECG changes, 
decrease in prothrombin time, 
hypocholesterolaemic effect etc. 
6. The widespread use of T.arjuna shows 
decrease in mortality rate by conventional 
treatment& improves quality of life. 
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